CSTB and cancer: By immunohistochemistry staining, the overexpression of CSTB was observed in human ovarian tumors, including benign, borderline and malignant tumors, albeit at different levels (Fig. 1A, B and C), compared with the normal ovarian tissues that showed negative staining (Fig. 1D).